PreprintPDF Available

Glutamic acid promotes hair growth in mice

September 2020

DOI:10.1101/2020.09.27.315523

Authors:

University of Nebraska Medical Center

Natália Ferreira Mendes

University of Campinas

Universidade Federal de Ouro Preto

Show all 8 authorsHide

Glutamic Acid is the main excitatory neurotransmitter in neurons. Abnormal distributions of the glutamic acid receptors have been shown in hyper proliferative models such as psoriasis and skin regeneration. However, the biological function of glutamic acid in the skin remains unclear. Using ex vivo, in vivo and in silico approaches, we showed for the first time that exogenous glutamic acid promotes hair growth and keratinocyte proliferation. Topical application of glutamic acid decreased expression of genes related to apoptosis signaling in the skin. Also, we showed Glutamic acid increased viability and proliferation in cultured human keratinocyte. For the first time, we identified the excitotoxic GA concentration and we provided evidence for the existence of a novel skin signaling pathway mediated by a neurotransmitter controlling keratinocyte and hair follicle proliferation. In perspective, we anticipate our results could be the starting point to elucidate how exogenous glutamic acid from food intake or even endogenous GA from neuropsychiatric disorders modulate skin diseases.

Content uploaded by Natália Ferreira Mendes

Content may be subject to copyright.

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

The copyright holder for this preprintthis version posted September 28, 2020. ; https://doi.org/10.1101/2020.09.27.315523doi: bioRxiv preprint

ResearchGate has not been able to resolve any citations for this publication.

ResearchGate has not been able to resolve any references for this publication.

Article

Full-text available

Glutamic acid promotes hair growth in mice

July 2021 · Scientific Reports

Glutamic acid is the main excitatory neurotransmitter acting both in the brain and in peripheral tissues. Abnormal distribution of glutamic acid receptors occurs in skin hyperproliferative conditions such as psoriasis and skin regeneration; however, the biological function of glutamic acid in the skin remains unclear. Using ex vivo, in vivo and in silico approaches, we showed that exogenous ... [Show full abstract] glutamic acid promotes hair growth and keratinocyte proliferation. Topical application of glutamic acid decreased the expression of genes related to apoptosis in the skin, whereas glutamic acid increased cell viability and proliferation in human keratinocyte cultures. In addition, we identified the keratinocyte glutamic acid excitotoxic concentration, providing evidence for the existence of a novel skin signalling pathway mediated by a neurotransmitter that controls keratinocyte and hair follicle proliferation. Thus, glutamic acid emerges as a component of the peripheral nervous system that acts to control cell growth in the skin. These results raise the perspective of the pharmacological and nutritional use of glutamic acid to treat skin diseases.

Article

Full-text available

Hypothalamic Microglial Heterogeneity and Signature under High Fat Diet-Induced Inflammation

February 2021 · International Journal of Medical Sciences

Under high-fat feeding, the hypothalamus atypically undergoes pro-inflammatory signal-ing activation. Recent data from transcriptomic analysis of microglia from rodents and humans has allowed the identification of several microglial subpopulations throughout the brain. Numerous studies have clarified the roles of these cells in hypothalamic inflammation, but how each microglial subset plays its ... [Show full abstract] functions upon inflammatory stimuli remains unexplored. Fortunately, these data unveiling microglial heterogeneity have triggered the development of novel experimental models for studying the roles and characteristics of each microglial subtype. In this review, we explore mi-croglial heterogeneity in the hypothalamus and their crosstalk with astrocytes under high fat diet-induced inflammation. We present novel currently available ex vivo and in vivo experimental models that can be useful when designing a new research project in this field of study. Last, we examine the transcriptomic data already published to identify how the hypothalamic microglial signature changes upon short-term and prolonged high-fat feeding.

Article

Full-text available

Interleukin-6 actions in the hypothalamus protects against obesity and is involved in the regulation...

August 2021 · Journal of Neuroinflammation

Interleukin-6 (IL6) produced in the context of exercise acts in the hypothalamus reducing obesity-associated inflammation and restoring the control of food intake and energy expenditure. In the hippocampus, some of the beneficial actions of IL6 are attributed to its neurogenesis-inducing properties. However, in the hypothalamus, the putative neurogenic actions of IL6 have never been explored, and ... [Show full abstract] its potential to balance energy intake can be an approach to prevent or attenuate obesity. Wild-type (WT) and IL6 knockout (KO) mice were employed to study the capacity of IL6 to induce neurogenesis. We used cell labeling with Bromodeoxyuridine (BrdU), immunofluorescence, and real-time PCR to determine the expression of markers of neurogenesis and neurotransmitters. We prepared hypothalamic neuroprogenitor cells from KO that were treated with IL6 in order to provide an ex vivo model to further characterizing the neurogenic actions of IL6 through differentiation assays. In addition, we analyzed single-cell RNA sequencing data and determined the expression of IL6 and IL6 receptor in specific cell types of the murine hypothalamus. IL6 expression in the hypothalamus is low and restricted to microglia and tanycytes, whereas IL6 receptor is expressed in microglia, ependymocytes, endothelial cells, and astrocytes. Exogenous IL6 reduces diet-induced obesity. In outbred mice, obesity-resistance is accompanied by increased expression of IL6 in the hypothalamus. IL6 induces neurogenesis-related gene expression in the hypothalamus and in neuroprogenitor cells, both from WT as well as from KO mice. IL6 induces neurogenesis-related gene expression in the hypothalamus of WT mice. In KO mice, the neurogenic actions of IL6 are preserved; however, the appearance of new fully differentiated proopiomelanocortin (POMC) and neuropeptide Y (NPY) neurons is either delayed or disturbed.

Article

Full-text available

Accelerative action of topical piperonylic acid on mice full thickness wound by modulating inflammat...

October 2021 · PLoS ONE

Epidermal growth factor (EGF) promotes cell growth, proliferation, and survival in numerous tissues. Piperonylic acid, a metabolite present in peppers ( Piper nigrum L. and Piper longum L.), can bind to the epidermal growth factor receptor (EGFR) and induce an intracellular signaling cascade leading to the transcription of genes responsible for these actions, especially in keratinocytes. These ... [Show full abstract] cells are fundamental in maintaining cutaneous homeostasis and are the first to be damaged in the case of a wound. Thus, we hypothesized that piperonylic acid improves wound healing. C57BL6/J male mice were submitted to dorsal skin wounds caused by a 6 mm punch and treated topically with piperonylic acid or vehicle. The wounds were evaluated macro- and microscopically, and tissue samples were collected for immunofluorescence and real-time PCR analyses on days 6, 9 and 19 post-injury. Topical piperonylic acid improved wound healing from day 6 post-injury until closure. This phenomenon apparently occurred through EGFR activation. In addition, piperonylic acid modulated the gene expression of interleukin ( Il )-6, il-1β, tumor necrosis factor ( Tnf )-α, il-10, monocyte chemoattractant protein ( Mcp )-1 and insulin-like growth factor ( Igf )-1, which are important for the healing process. By day 19 post-injury, the new tissue showed greater deposition of type I collagen and a morphology closer to intact skin, with more dermal papillae and hair follicles. We conclude that piperonylic acid may be a viable option for the treatment of skin wounds.